 |
 |

Induced Panic Attacks Shift -Aminobutyric Acid Type A Receptor Modulatory Neuroactive Steroid Composition in Patients With Panic Disorder
Preliminary Results
Andreas Ströhle, MD;
Elena Romeo, MD;
Flavia di Michele, MD;
Augusto Pasini, MD;
Bettina Hermann, PhD;
Gisela Gajewsky;
Florian Holsboer, MD, PhD;
Rainer Rupprecht, MD
Arch Gen Psychiatry. 2003;60:161-168.
Background Certain metabolites of progesterone such as 3 ,5 -tetrahydroprogesterone (3 ,5 -THP; allopregnanolone) and 3 ,5 -THP (pregnanolone) are potent, positive allosteric modulators of -aminobutyric acid type A receptors. Although animal studies suggest anxiolytic properties of these endogenous modulators of central nervous excitability, no clinical data indicate whether they are also involved in the pathophysiology of anxiety disorders and panic attacks.
Methods We quantified the concentrations of 3 ,5 -THP, 3 ,5 -THP, the isomer 3 ,5 -THP, and their precursors in the plasma of 10 patients with panic disorder and matched control subjects during panic attacks induced by means of sodium lactate and cholecystokinin tetrapeptide administration, using a highly sensitive gas chromatographymass spectrometry analysis.
Results Panic attacks induced by sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder were accompanied by pronounced decreases in the concentrations of 3 ,5 -THP and 3 ,5 -THP and a concomitant increase in the concentrations of the functional antagonistic isomer 3 ,5 -THP, findings that are compatible with a decreased -aminobutyric acidergic tone. No changes in neuroactive steroid concentrations were observed after placebo administration in patients with panic disorder or after placebo, sodium lactate, or cholecystokinin tetrapeptide administration in controls.
Conclusions The association between changes in plasma neuroactive steroid concentrations and experimentally induced panic attacks and the well-documented pharmacological properties of these compounds as -aminobutyric acid type A receptor modulators suggest that neuroactive steroids may play a role in the pathophysiology of panic attacks in patients with panic disorder.
From the Max Planck Institute of Psychiatry, Munich, Germany (Drs Ströhle, Hermann, Holsboer, and Rupprecht and Ms Gajewsky); and Tor Vergata University, IRCCS Santa Lucia, Rome, Italy (Drs Romeo, di Michele, and Pasini). Dr Ströhle is now with the Department of Psychiatry and Psychotherapy, Charité Hospital, Humboldt University at Berlin, Berlin, Germany.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Altered Cerebral {gamma}-Aminobutyric Acid Type A-Benzodiazepine Receptor Binding in Panic Disorder Determined by [11C]Flumazenil Positron Emission Tomography
Hasler et al.
Arch Gen Psychiatry 2008;65:1166-1175.
ABSTRACT
| FULL TEXT
Role of Microsomal Retinol/Sterol Dehydrogenase-Like Short-Chain Dehydrogenases/Reductases in the Oxidation and Epimerization of 3{alpha}-Hydroxysteroids in Human Tissues
Belyaeva et al.
Endocrinology 2007;148:2148-2156.
ABSTRACT
| FULL TEXT
Angiotensin-II Is a Putative Neurotransmitter in Lactate-Induced Panic-Like Responses in Rats with Disruption of GABAergic Inhibition in the Dorsomedial Hypothalamus
Shekhar et al.
J. Neurosci. 2006;26:9205-9215.
ABSTRACT
| FULL TEXT
The Acute Antipanic Activity of Aerobic Exercise
Strohle et al.
Am. J. Psychiatry 2005;162:2376-2378.
ABSTRACT
| FULL TEXT
|